biotics, was produced by an undetermined species of Streptomyces, which also produced paromomycin I and paromomycin 11. A purified sample of LL-BM408 was found to have activity against gram-negative bacterial infections in mice. LL-BM408 was identified as ribosyl paromamine (I) based on identification of acid hydrolysis fragments, nmr and mass spectral analyses.
Although ribosyl paromamine was prepared by chemical degradation of antibiotic BU-1709E22) and paromomycin,3) this appears to be the first time that it has been detected as a direct fermentation product.
LL-BM408 was produced by the fermentation of the organism on a medium containing dextrose, glycerol, soy flour, sodium chloride and calcium carbonate.
The course of antibiotic production was followed by inhibition of Klebsiella pneumoniae by the cup agar-diffusion method.
LL-BM408 was isolated by a sequence of steps involving ion-exchange chromatography on weak cationic exchange resins marketed as Amberlite IRC-50 (NH4+) and CG-50 (NH4+), and ion exclusion chromatography on a strong anion exchange resin marketed as Dowex 1-X2 (OH-).
The mixture of antibiotics in the purified fractions prepared this way could be readily resolved on an analytical scale by ion exclusion chromatography ( Fig. 1) as described by MAEHR and SCHAFFNER,4> or by adsorption to Amberlite CG-50 (NH4+) resin and stepwise elution with 0.1 N NH4OH by a procedure similar to that described by M. MURASE and co-workers." The former procedure involved the use of a strongly basic anion exchange resin of low cross linkage, Dowex 1-X2 resin, in the hydroxyl form. In the application of this technique to the LL-BM408 complex, the column was eluted with water and the effluent was monitored simultaneously by an automated trinitrobenzenesulfonic acid procedures) and by in vitro bioactivity. LL-BM408 was obtained as a white powder, [a];,5x-47°±4° (c 0.256, H2O).
Mass spectra of N-acetyl-O-trimethylsilyl derivatives and ion exclusion column retention times indicated two of the components were paromomycins I and II.
The fragmentation pattern of the N-acetyl-Otrimethylsilyl derivative of LL-BM408 is rationalized according to those commonly encountered for this type of derivative of aminocyclitol antibiotics.7) The highest mass peak at m/e 1070 is attributed to the loss of a methyl radical. Peaks at m/e 838 and 767 are re-arrangement ions resulting from fragmentation and migration of TMSO groups. A strong m/e 838 ion is characteristic of antibiotics having paromamine linked to a sugar moiety. Fragmentations to give peaks at m/e 420 and 649 are indicative of a terminal aminohexose and a terminal pentose linked to deoxystreptamine.
Confirmation of these fragmentations was obtained by peak matching studies (Table 1) which showed the found masses are within 10 ppm of the calculated values. In addition, the low resolu- On paper chromatography, glucosamine and a hydrolysis fragment from LL-BM408 traveled the same distance from the origin (1.7 cm) and gave the same color reactions with the sprays.
The nmr spectrum of LL-BM408 is consistent with the proposed structure. It shows two anomeric protons at 8 5.45 and 5.63 with coupling constants of <4Hz, corresponding to those of the glucosamine and ribose moieties.
The magnitudes of the coupling constants are in agreement with model systems having similar furanose configuration about the anomeric proton, but this assignment is not definitive.
LL-BM408 had Rparomamfne 0.83 in the system CHCl3-MCOH-NH4OH (1: 3:2) on silica gel as would be predicted from the results reported. 3, 8) This Rf is significantly different from that of the corresponding compound with the alternative location of ribose on deoxystreptamine. All of the data presented are consistent for LL-BM408 having structure I.
LL-BM408 protected mice (1/2 survivors at 64 mg/kg and 2/2 survivors at 128mg/kg) infected with Proteus mirabilis when administered parenterally and inhibited in vitro a number of gramnegative bacteria (Table 2) .
